Live Breaking News & Updates on Davidp Luci

Stay updated with breaking news from Davidp luci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Robertg-shawah , Davidp-luci , Kevin-garey , Acurx-pharmaceuticals , International-cdifficile-symposium , European-medicines-agency , Prnewswire-acurx-pharmaceuticals-inc , Acurx-pharmaceuticals-inc , Anaerobe-society-of-america , Drug-administration

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of. ....

United-states , Spain , Barcelona , Comunidad-autonoma-de-cataluna , Switzerland , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Company-ph , Society-or-healthcare-epidemiology-of-america , Global-european-society-of-clinical-microbiology

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of. ....

United-states , Spain , Switzerland , Barcelona , Comunidad-autonoma-de-cataluna , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Society-or-healthcare-epidemiology-of-america , Exchange-commission , Research-scientist

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical. ....

United-states , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Switzerland , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Acurx-pharmaceuticals-announces-presentation-of-ibezapolostat-phase , Nasdaq , University-of-houston-college-pharmacy

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

STATEN ISLAND, N.Y., April 23, 2024 /PRNewswire/ Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial. ....

Robertg-shawah , Davidp-luci , Prnewswire-acurx-pharmaceuticals-inc , Drug-administration , Acurx-pharmaceuticals , Nasdaq , Acurx-pharmaceuticals-inc , Exchange-commission-on-form , Chief-executive-officer , Chief-financial-officer , Gram-positive-selective-spectrum